An Epstein-Barr virus positive natural killer lymphoma xenograft derived for drug testing

References

• Kim G E, Lee S W, Chang S K, Park H C, Pyo H R, Kim J H, et al. Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck. Radiother Oncol 2001; 61: 261–269
   PubMed Web of Science ®Google Scholar
• Kwong Y L. Natural killer-cell malignancies: diagnosis and treatment. Leukemia 2005; 19: 2186–2194
   PubMed Web of Science ®Google Scholar
• Chan J, Jaffe E S, Ralfkiaer E. Extranodal NK/T cell lymphoma, nasal type. IARC Press, Lyon 2001
   Google Scholar
• Nava V E, Jaffe E S. The pathology of NK-cell lymphomas and leukemias. Adv Anat Pathol 2005; 12: 27–34
   PubMed Web of Science ®Google Scholar
• Kawa-Ha K, Ishihara S, Ninomiya T, Yumura-Yagi K, Hara J, Murayama F, et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 1989; 84: 51–55
   PubMed Web of Science ®Google Scholar
• Hart D N, Baker B W, Inglis M J, Nimmo J C, Starling G C, Deacon E, et al. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood 1992; 79: 2116–2123
   PubMed Web of Science ®Google Scholar
• Kim G E, Cho J H, Yang W I, Chung E J, Suh C O, Park K R, et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol 2000; 18: 54–63
   PubMed Web of Science ®Google Scholar
• Cheung M M, Chan J K, Lau W H, Ngan R K, Foo W W. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 2002; 54: 182–190
   PubMed Web of Science ®Google Scholar
• Lee K W, Yun T, Kim D W, Im S A, Kim T Y, Yoon S S, et al. First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/− radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma. Leuk Lymphoma 2006; 47: 1274–1282
   PubMed Web of Science ®Google Scholar
• Ando M, Sugimoto K, Kitoh T, Sasaki M, Mukai K, Ando J, et al. Selective apoptosis of natural killer-cell tumours by l-asparaginase. Br J Haematol 2005; 130: 860–868
   PubMed Web of Science ®Google Scholar
• Yong W, Zheng W, Zhu J, Zhang Y, Wei Y, Wang X, et al. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of l-asparaginase based regimen, and prognostic factors. Hematol Oncol 2006; 24: 28–32
   PubMed Web of Science ®Google Scholar
• Huynh H, Soo K C, Chow P K, Panasci L, Tran E. Xenografts of human hepatocellular carcinoma: a useful model for testing drugs. Clin Cancer Res 2006; 12: 4306–4314
   PubMed Web of Science ®Google Scholar
• Witzig T E, Geyer S M, Ghobrial I, Inwards D J, Fonseca R, Kurtin P, et al. Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma. J Clin Oncol 2005; 23: 5347–5356
   PubMed Web of Science ®Google Scholar
• Man S, Bocci G, Francia G, Green S K, Jothy S, Hanahan D, et al. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water. Cancer Res 2002; 62: 2731–2735
   PubMed Web of Science ®Google Scholar
• Kerbel R S. Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived—but they can be improved. Cancer Biol Ther 2003; 2: S134–S139
   PubMed Web of Science ®Google Scholar
• Kagami Y, Nakamura S, Suzuki R, Iida S, Yatabe Y, Okada Y, et al. Establishment of an IL-2-dependent cell line derived from ‘nasal-type’ NK/T-cell lymphoma of CD2+, sCD3−, CD3ε+, CD56+ phenotype and associated with the Epstein-Barr virus. Br J Haematol 1998; 103: 669–677
   PubMed Web of Science ®Google Scholar
• Matsuo Y, Drexler H G. Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma. Leuk Res 2003; 27: 935–945
   PubMed Web of Science ®Google Scholar
• Au W Y, Lie A K, Liang R, Kwong Y L, Yau C C, Cheung M M, et al. Autologous stem cell transplantation for nasal NK/T-cell lymphoma: a progress report on its value. Ann Oncol 2003; 14: 1673–1676
   PubMed Web of Science ®Google Scholar
• Kim H J, Bang S M, Lee J, Kwon H C, Suh C, Kim H J, et al. High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases. Bone Marrow Transplant 2006; 37: 819–824
   PubMed Web of Science ®Google Scholar
• Kerbel R S, Kamen B A. The anti-angiogenic basis of metronomic chemotherapy. Nat Rev Cancer 2004; 4: 423–436
   PubMed Web of Science ®Google Scholar
• Vose J. International peripheral T-cell lymphoma (PTCL) clinical and pathological review project: poor outcome by prognostic indices and lack of efficacy with anthracyclines. 47th Annual Meeting of the American Society of Hematology, AtlantaGeorgia, 2005; 811
   Google Scholar